1901 - 1950 of 8571 Results
Title
Year
-
OPENTitle: Clinical deep brain stimulation strategies for orientation-selective pathway activationJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 15Issue #: 5Start Page: 056029End Page: 056029Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1088/1741-2552/aad978Best OA location URL: http://iopscience.iop.org/article/10.1088/1741-2552/aad978/pdfCitation Count: 54
-
RESTRICTEDTitle: Foundations for a Patient-Reported Natural History of Parkinson Disease: Cross sectional Analysis of the MJFF Fox Insight (FI) Platform (P2.056)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p2.056Citation Count: 1
-
OPENTitle: The emerging postural instability phenotype in idiopathic Parkinson diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00287-xBest OA location URL: https://www.nature.com/articles/s41531-022-00287-x.pdfCitation Count: 20
-
RESTRICTEDTitle: Very low levels of ABCA7 in the cerebrum and Alzheimer’s disease onset between the ages of 60 and 80 independently of APOEJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 83Issue #: 10Start Page: 808End Page: 821Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlae060Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11413437Citation Count: 1
-
OPENTitle: Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 64Issue #:Start Page: 79End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2013.12.011Best OA location URL: https://doi.org/10.1016/j.nbd.2013.12.011Citation Count: 81
-
OPENTitle: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformationsJournal Name: Protein SciencePublisher: WileyVol: 31Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pro.4360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.4360Citation Count: 9
-
OPENTitle: The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier statusJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00778-8Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-021-00778-8Citation Count: 54
-
RESTRICTEDTitle: Biallelic NUDT2 variants defective in mRNA decapping cause a neurodevelopmental diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 4Start Page: 1197End Page: 1205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awad434Best OA location URL: https://hal.science/hal-05121495v1/file/awad434.pdfCitation Count: 7
-
OPENTitle: A connectomics-based taxonomy of mammalsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.78635Best OA location URL: https://cdn.elifesciences.org/articles/78635/elife-78635-v2.pdfCitation Count: 25
-
OPENTitle: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 9Start Page: 2286End Page: 2286Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10092286Best OA location URL: https://www.mdpi.com/2073-4409/10/9/2286/pdf?version=1630925823Citation Count: 13
-
OPENTitle: Multimodal assessment of mitochondrial function in Parkinson's diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 1Start Page: 267End Page: 280Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awad364Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awad364/54040745/awad364.pdfCitation Count: 17
-
OPENTitle: An alpha‐synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progressionJournal Name: PROTEOMICS – Clinical ApplicationsPublisher: WileyVol: 11Issue #: 7-8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/prca.201700045Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5540649Citation Count: 19
-
OPENTitle: In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathiesJournal Name: Nuclear Medicine and BiologyPublisher: Elsevier BVVol: 130-131Issue #:Start Page: 108891End Page: 108891Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nucmedbio.2024.108891Citation Count: 9
-
OPENTitle: Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 642End Page: 650Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28360Citation Count: 74
- Long-lasting effects of transcranial static magnetic field stimulation on motor cortex excitability2018RESTRICTEDTitle: Long-lasting effects of transcranial static magnetic field stimulation on motor cortex excitabilityJournal Name: Brain StimulationPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 676End Page: 688Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.02.005Citation Count: 66
- Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief Report2025OPENTitle: Polysomnographic (PSG) Characteristics of Sleep Behaviour in Parkinson's Disease: A Brief ReportJournal Name: Journal of Sleep ResearchPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/jsr.70108Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jsr.70108Citation Count: 0
-
OPENTitle: Phos-tag analysis of Rab10 phosphorylation by LRRK2: a powerful assay for assessing kinase function and inhibitorsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 473Issue #: 17Start Page: 2671End Page: 2685Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20160557Best OA location URL: https://portlandpress.com/biochemj/article-pdf/473/17/2671/687564/bj4732671.pdfCitation Count: 156
-
OPENTitle: Progression of regional cortical cholinergic denervation in Parkinson’s diseaseJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 4Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/braincomms/fcac320Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcac320/47516536/fcac320.pdfCitation Count: 25
-
OPENTitle: PINK1 regulated mitophagy is evident in skeletal musclesJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 3Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1080/27694127.2024.2326402Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/27694127.2024.2326402?needAccess=trueCitation Count: 11
-
OPENTitle: Differential cholinergic systems’ changes in progressive supranuclear palsy versus Parkinson’s disease: an exploratory analysisJournal Name: Journal of Neural TransmissionPublisher: Springer Science and Business Media LLCVol: 129Issue #: 12Start Page: 1469End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00702-022-02547-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10017092Citation Count: 6
-
OPENTitle: Alzheimer's disease traits in Parkinson's disease without α‐synuclein seedingJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 21Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.70284Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.70284Citation Count: 0
-
OPENTitle: Bach1 derepression is neuroprotective in a mouse model of Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 118Issue #: 45Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2111643118Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8694049Citation Count: 63
-
OPENTitle: Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorderJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 1Start Page: 201End Page: 212Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51269Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51269Citation Count: 49
-
OPENTitle: Detecting alpha-synuclein aggregates with small molecules on single-molecule arrayJournal Name: Chemical SciencePublisher: Royal Society of Chemistry (RSC)Vol: 16Issue #: 29Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1039/d4sc07649dBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2025/sc/d4sc07649dCitation Count: 0
-
OPENTitle: Regulation of LRRK2 activity by metabolic stress and heavy metal exposureJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1863Issue #:Start Page: 149785End Page: 149785Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2025.149785Best OA location URL: https://doi.org/10.1016/j.brainres.2025.149785Citation Count: 0
-
OPENTitle: Harmonization of Structural Brain Connectivity Through Distribution MatchingJournal Name: Human Brain MappingPublisher: WileyVol: 46Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.70257Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/hbm.70257Citation Count: 0
-
RESTRICTEDTitle: Higher urate in LRRK2 mutation carriers resistant to Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 85Issue #: 4Start Page: 593End Page: 599Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.25436Citation Count: 52
-
RESTRICTEDTitle: Exploring the Experience of Wearing Off in Parkinson’s Disease: A Qualitative Research Approach (P5.8-050)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 92Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p5.8-050Citation Count: 0
-
OPENTitle: Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophyJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-019-0164-xBest OA location URL: https://translationalneurodegeneration.biomedcentral.com/track/pdf/10.1186/s40035-019-0164-xCitation Count: 145
-
OPENTitle: Dynamics of Nigral Iron Accumulation in Parkinson's Disease: From Diagnosis to Late StageJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 8Start Page: 1654End Page: 1662Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29062Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9810258Citation Count: 32
-
RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 0
-
OPENTitle: Patient-specific analysis of the relationship between the volume of tissue activated during DBS and verbal fluencyJournal Name: NeuroImagePublisher: Elsevier BVVol: 54Issue #:Start Page: S238End Page: S246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2010.03.068Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2908727Citation Count: 111
-
RESTRICTEDTitle: Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 147Issue #: 11Start Page: 3702End Page: 3713Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awae303Citation Count: 4
-
OPENTitle: BRF110, an Orally Active Nurr1-RXRα-Selective Rexinoid, Enhances BDNF Expression without Elevating TriglyceridesJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 68Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.4c03046Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c03046Citation Count: 4
-
OPENTitle: GDNF signaling in subjects with minimal motor deficits and Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 153Issue #:Start Page: 105298End Page: 105298Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105298Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105298Citation Count: 24
-
OPENTitle: LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficitsJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 12Issue #: 540Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aav0820Best OA location URL: https://stm.sciencemag.org/content/scitransmed/12/540/eaav0820.full.pdfCitation Count: 108
-
RESTRICTEDTitle: Baseline α-synuclein seeding activity and disease progression in sporadic and genetic Parkinson's disease in the PPMI cohortJournal Name: eBioMedicinePublisher: Elsevier BVVol: 119Issue #:Start Page: 105866End Page: 105866Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105866Best OA location URL: https://www.thelancet.com/pdfs/journals/ebiom/PIIS2352-3964(25)00310-X.pdfCitation Count: 0
-
OPENTitle: Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 HeteromersJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 7Issue #: 9Start Page: 1201End Page: 1211Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.6b00036Best OA location URL: http://doi.org/10.1021/acschemneuro.6b00036Citation Count: 57
-
OPENTitle: Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 44Issue #: 5Start Page: 115636End Page: 115636Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2025.115636Best OA location URL: https://doi.org/10.1016/j.celrep.2025.115636Citation Count: 0
-
OPENTitle: Developing better digital health measures of Parkinson’s disease using free living data and a crowdsourced data analysis challengeJournal Name: PLOS Digital HealthPublisher: Public Library of Science (PLoS)Vol: 2Issue #: 3Start Page: e0000208End Page: e0000208Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pdig.0000208Best OA location URL: https://journals.plos.org/digitalhealth/article/file?id=10.1371/journal.pdig.0000208&type=printableCitation Count: 5
-
RESTRICTEDTitle: Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liabilityJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 28Issue #: 15Start Page: 2641End Page: 2646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2018.06.034Best OA location URL: https://doi.org/10.7270/q2dr2z5hCitation Count: 13
- Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression2015OPENTitle: Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progressionJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 37Issue #:Start Page: 209.e1End Page: 209.e7Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2015.09.014Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2015.09.014Citation Count: 103
-
OPENTitle: Development and characterization of phospho-ubiquitin antibodies to monitor PINK1-PRKN signaling in cells and tissueJournal Name: AutophagyPublisher: Informa UK LimitedVol: 20Issue #: 9Start Page: 2076End Page: 2091Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1080/15548627.2024.2356490Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2024.2356490Citation Count: 5
-
OPENTitle: Modulation of cannabinoid receptor 2 alters neuroinflammation and reduces formation of alpha-synuclein aggregates in a rat model of nigral synucleinopathyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 21Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-024-03221-5Best OA location URL: https://link.springer.com/content/pdf/10.1186/s12974-024-03221-5.pdfCitation Count: 3
-
OPENTitle: Comprehensive subtyping of Parkinson’s disease patients with similarity fusion: a case study with BioFIND dataJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00228-0Best OA location URL: https://www.nature.com/articles/s41531-021-00228-0.pdfCitation Count: 17
-
OPENTitle: Design of a virtual longitudinal observational study in Parkinson’s disease (AT‐HOME PD)Journal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 2Start Page: 308End Page: 320Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.51236Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51236Citation Count: 28
-
OPENTitle: Disruption of the LRRK2‐FADD Interface Using Constrained PeptidesJournal Name: Peptide SciencePublisher: WileyVol: 116Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/pep2.24374Best OA location URL: https://onlinelibrary.wiley.com/doi/pdf/10.1002/pep2.24374Citation Count: 0
- Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatum2018RESTRICTEDTitle: Evidence for encephalopsin immunoreactivity in interneurones and striosomes of the monkey striatumJournal Name: Experimental Brain ResearchPublisher: Springer Science and Business Media LLCVol: 236Issue #: 4Start Page: 955End Page: 961Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00221-018-5191-9Citation Count: 19
-
RESTRICTEDTitle: Biomarkers for Parkinson’s DiseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 3Issue #: 79Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488Citation Count: 42
-
OPENTitle: Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer’s disease and Parkinson’s diseaseJournal Name: Translational NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40035-024-00400-5Best OA location URL: https://translationalneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s40035-024-00400-5Citation Count: 13